Tradestie Institutional Equity Comparison Engine

FEED vs XBIO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

XBIO Overall Edge

XBIO Captures Institutional Edge (2โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xenetic Biosciences, Inc. (XBIO) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, FEED trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus XBIO at N/M Forward P/E and -81.0% operating margin (+12.0% YoY). In options structure, FEED sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against XBIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
FEED N/M vs XBIO N/M Fwd P/E
Growth & Margin Winner XBIO
Op Margin N/A vs -81.0% ยท YoY N/A vs +12.0%
Momentum & Technical Winner XBIO
1Y -75.3% vs -44.9% ยท 52W Pos 13% vs 4%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
FEED US Equity
FEED
Institutional Equity
$1.03
-69.25% 1D
Market Cap N/A
1M Return +135.7%
1Y Return -75.27%
Forward P/E N/M
Unified AI Score
37.1 / 100 SELL
Tech 15.0 Fund 28.0 Flow 50.0 Mom 40.0
XBIO NASDAQ
Xenetic Biosciences, Inc.
Pharmaceutical Preparations
$1.40
-9.09% 1D
Market Cap $3.6M
1M Return -27.46%
1Y Return -44.88%
Forward P/E N/M
Unified AI Score
43.5 / 100 HOLD
Tech 25.0 Fund 56.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FEED -75.27% XBIO -44.88% Spread: +150.99 pp (XBIO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
FEED TTM Op. Margin: N/A XBIO TTM Op. Margin: -81.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FEED vs XBIO. Trailing 12-month operating profitability (FEED N/A vs XBIO -81.0%) and valuation multiples (FEED N/M vs XBIO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FEED (1) vs XBIO (7)
Institutional Metric FEED XBIO Criterion Row Winner
Market Capitalization Scale N/A $3.6M Larger Scale XBIO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +12.0% Higher Growth XBIO
Operating Margin (TTM) Profitability N/A -81.0% Higher Margin XBIO
Net Profit Margin Profitability N/A -75.9% Higher Margin XBIO
Return on Equity (ROE) Capital Efficiency N/A -47.0% Higher ROE XBIO
52-Week Range Position Momentum 13% ($0โ€“$6) 4% ($1โ€“$5) Stronger Trend FEED
Beta / 30D Volatility Risk Regime -6.40ฮฒ ยท 3942% Vol 1.40ฮฒ ยท 99% Vol Lower Realized Risk XBIO
Unified Institutional Score Composite Signal 37.1 / 100 (SELL) 43.5 / 100 (HOLD) Higher Composite XBIO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FEED vs XBIO Buy Guide
FEED UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FEED Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XBIO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live XBIO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FEED nor XBIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.